HMNC Brain Health develops patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders.Founded in 2010, the privately held biotech company combines the development of machine learning-enabled companion diagnostics with specifictherapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression. The ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. HMNC Brain Health strives to reduce not only the immense individual burden but also the societal impact of these diseases.

Biotechnology

Health Care

Pharmaceutical

Therapeutics

HMNC Brain Health

Florian Holsboer

Benjamin Boerger

Theresa Pfeiffer

Hans Eriksson M.D. Mba

Dr. Christine Zu Eulenburg

Clinical Development Team

Leadership Team

Teams at HMNC Brain Health

Clinical Development Team

Leadership Team